Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Bone Stimulator for Spondylolysis

NCT: NCT06666608 · RECRUITING

NCT IDNCT06666608
StatusRECRUITING
Start Date2025-12-03
Completion2029-12

Brief Summary

This prospective study aims to investigate the effectiveness of bone stimulator therapy as adjunct treatment of spondylolysis in athletic populations. By evaluating its impact on pain reduction, functional improvement, osseous bony union and return-to-sport time, the investigators seek to provide valuable insights into the role of bone stimulation therapy as a potential treatment modality for this challenging condition.

Frequently Asked Questions

What is Bone Stimulator for Spondylolysis?

Bone Stimulator for Spondylolysis is a clinical trial registered under NCT06666608. Current status: RECRUITING.

What is the status of NCT06666608?

The current status of NCT06666608 (Bone Stimulator for Spondylolysis) is: RECRUITING.

When did Bone Stimulator for Spondylolysis start?

Bone Stimulator for Spondylolysis started on 2025-12-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.